Initial Management of Liver Cirrhosis
The initial management of liver cirrhosis centers on treating the underlying cause to prevent progression, implementing sodium restriction with diuretic therapy for ascites if present, and initiating comprehensive monitoring for complications. 1, 2
Treat the Underlying Etiology First
This is the cornerstone of cirrhosis management and can potentially reverse early cirrhosis: 2
- Alcohol-related cirrhosis: Mandate complete and permanent alcohol cessation, as this may lead to "re-compensation" and improved outcomes 1, 2
- Viral hepatitis B: Initiate antiviral therapy (tenofovir or entecavir) regardless of ALT levels in patients with compensated cirrhosis and HBV DNA ≥2,000 IU/mL, as this prevents disease progression and reduces hepatocellular carcinoma risk 3
- Viral hepatitis C: Treat with direct-acting antivirals, which can improve liver function and reduce portal hypertension 2
- Nonalcoholic steatohepatitis: Address metabolic syndrome components including weight loss, diabetes control, and lipid management 4
Initial Assessment for Complications
Determine if the patient has compensated versus decompensated cirrhosis, as this fundamentally changes management: 1
- Compensated cirrhosis: Patients are asymptomatic without ascites, variceal bleeding, or hepatic encephalopathy 4
- Decompensated cirrhosis: Any presence of ascites, variceal bleeding, hepatic encephalopathy, or jaundice requires immediate gastroenterology referral 1
Management of Ascites (If Present)
First-line treatment consists of sodium restriction (88 mmol or 2000 mg per day) combined with oral diuretics (spironolactone with or without furosemide). 3, 1
For New-Onset or Mild Ascites:
- Start spironolactone 100 mg daily and furosemide 40 mg daily 3
- Titrate doses upward every 3-5 days until achieving weight loss of 0.5 kg/day (without peripheral edema) or 1 kg/day (with peripheral edema) 3
- Maximum doses: spironolactone 400 mg/day and furosemide 160 mg/day 3
- Fluid restriction is NOT necessary unless serum sodium drops below 120-125 mmol/L 3, 1
For Tense Ascites:
- Perform initial large-volume paracentesis immediately to relieve symptoms 3, 1
- Administer intravenous albumin (8 g per liter of fluid removed) if removing >5 liters 3
- Follow paracentesis with sodium restriction and diuretic therapy to prevent reaccumulation 3
Critical Medications to AVOID:
- NSAIDs must be avoided as they reduce urinary sodium excretion and can convert diuretic-sensitive ascites to refractory ascites 3, 1
- Avoid nephrotoxic drugs including aminoglycosides 3
- Discontinue ACE inhibitors, ARBs, and other vasodilators 3
Patient Education Requirements
Provide specific counseling on: 1
- Salt restriction techniques (reading labels, avoiding processed foods, no added salt)
- Daily weight monitoring (report gain >2 kg in one week)
- Medication adherence importance
- Recognition of warning signs: increased abdominal girth, confusion, black stools, vomiting blood, fever
Monitoring Schedule
For Compensated Cirrhosis:
- Hepatocellular carcinoma screening with ultrasound every 6 months 4
- Upper endoscopy to screen for varices at diagnosis, then per protocol based on findings 4
- Laboratory monitoring (CBC, comprehensive metabolic panel, PT/INR) every 3-6 months 4
For Decompensated Cirrhosis:
- More frequent monitoring every 2-4 weeks initially until stable response to treatment is confirmed 3
- Immediate gastroenterology referral for transplant evaluation 1
When to Refer to Gastroenterology
Immediate referral is required for: 1
- Any decompensation event (ascites, variceal bleeding, hepatic encephalopathy)
- Refractory ascites not responding to maximum diuretic therapy
- Need for TIPS evaluation
- Liver transplantation evaluation
Common Pitfalls to Avoid
- Do not delay treatment of underlying etiology while focusing only on complications 2
- Do not restrict fluids in ascites patients unless hyponatremia is severe (<120-125 mmol/L) 3, 1
- Do not use serial paracenteses as first-line therapy when diuretics would be effective 3
- Do not prescribe NSAIDs, even for minor pain complaints 1
- Do not overlook the need for hepatocellular carcinoma surveillance in all cirrhosis patients 4